Despite seeing encouraging results, the New Brunswick woman says she doesn't qualify for a program that helps pay for food ...

WELL, AN ASSISTANT PROFESSOR AT THE UNIVERSITY OF NEW MEXICO HAS JUST RECEIVED A GRANT TO CONDUCT MORE RESEARCH ON THE ...

BerGenBio, reeling from the failure of its lead cancer drug, has opted to merge with fellow Norwegian cancer biotech Oncoinvent.

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when ...

The Bureau of Investigative Journalism (TBIJ) revealed that commonly used chemotherapy drugs around the world had failed ...

Obesity, a growing global epidemic, is identified as a significant, modifiable risk factor for ovarian cancer, a deadly ...

Low-grade serous ovarian cancer (LGSC), accounts for just 5% to 10% of all epithelial ovarian cancers, but its distinct biology makes it especially challenging to treat. While the origin of this ...

Ovarian cancer in particular ... doesn't have great survival,” said one researcher. “Anything we can do to better understand ...

Clinical application: Treatment in a mouse model with milciclib in combination with mirvetuximab significantly reduced tumor ...

Chris Evert says she now considers every day "precious" after twice battling cancer and admits that getting to "the lowest ...

Anixa Biosciences advances CAR T-cell therapy for recurrent ovarian cancer, targeting FSHR with promising safety and efficacy ...

A new technique lets researchers make many more of the particles much faster, using consistent practices that meet safety ...